Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Söndag 31 Maj | 20:57:54 Europe / Stockholm

Svenska | English

Xenon Pharmaceuticals

Beskrivning

Land	Kanada
Lista	77
Sektor	Hälsovård
Industri	Bioteknik

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Filter

År

Typ

Språk

Rensa

2026-05-29 22:01:00 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 54,73 USD | -0,11%

2026-05-07 22:01:00 Xenon Reports Q1 2026 Financial Results and Provides Business Update 56,00 USD | -4,42%

2026-05-01 22:01:00 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 56,13 USD | +0,16%

2026-04-30 22:01:00 Xenon to Report Q1 2026 Financial Results on May 7, 2026 56,04 USD | +0,52%

2026-04-20 00:00:00 Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting 57,09 USD | -4,37%

Xenon Pharmaceuticals

Beskrivning

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden